Abiopharma

Stoke Therapeutics Announces Updates to Timelines for the Completion of Enrollment and a Phase 3 Data Readout from the EMPEROR Study of Zorevunersen for the Treatment of Dravet Syndrome

Krystal Biotech Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference

10x Genomics - 10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results

IDEAYA Biosciences Provides a Business Update and Outlines 2026 Corporate Objectives at the 44th Annual J.P. Morgan Healthcare Conference

10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results

RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer

Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response

Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response

Scatec signs landmark PPA in Egypt for 1.95 GW Solar and 3.9 GWh BESS capacity

Pfizer Inc. - Pfizer’s BRAFTOVI® Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer